✦ LIBER ✦

MC13-0078 PARP1 variants associated with response to Temozolomide in metastatic melanoma patients

✍ Scribed by Sedgewick, A.; Romkes, M.; Buch, S.; Villaruz, L.; Abecassis, I.; Saul, M.; Kirkwood, J.M.; Benos, P.V.; Tawbi, H.

Book ID: 122335179
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 68 KB
Volume: 49
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(13)70184-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunological characteristics correlatin

Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma

✍ MARSHALL, JULIA A; FORSTER, TREVOR H; PURDIE, DAVID M; LANAGAN, CATHERINE M; O'C 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 252 KB

Clinical response after intradermal imma

Clinical response after intradermal immature dendritic cell vaccination in metastatic melanoma is associated with immune response to particulate antigen

✍ Mark Smithers; Kathleen O'Connell; Susan MacFadyen; Melita Chambers; Kathryn Gre 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 460 KB

Cytoplasmic melanoma-associated antigen

Cytoplasmic melanoma-associated antigen (CYT-MAA) serum level in patients with melanoma: A potential marker of response to immunotherapy?

✍ Sandra R. Reynolds; Irene J. Vergilis; Michael Szarek; Soldano Ferrone; Jean-Cla 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 135 KB

## Abstract Simple, noninvasive methods are needed to follow effectiveness of new treatments in patients with melanoma. In our study, we examined cytoplasmic melanoma‐associated antigen (CYT‐MAA) serum level in melanoma patients during immunotherapy. Sera of 117 patients were assayed for CYT‐MAA by

Initial Clinical Response Predicts Outco

Initial Clinical Response Predicts Outcome and Is Associated With Dose Schedule in Metastatic Melanoma and Renal Cell Carcinoma Patients Treated With High-Dose Interleukin 2

✍ Kathryn Spanknebel; Kenneth Y. Cheung; John Stoutenburg; Karl Hurst-Wicker; Char 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 133 KB

Initial clinical response predicts outco

Initial clinical response predicts outcome and is associated with dose schedule in metastatic melanoma and renal cell carcinoma patients treated with high-dose interleukin-2

✍ K. Spanknebel; K. Hurst-Wicker; Y. K. Cheung; C. Hesdorffer; G. DeRaffele; H. Ka 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 148 KB

Tu1925 Novel Pathway-Centric Analysis Re

Tu1925 Novel Pathway-Centric Analysis Reveals Variants Associated With Toxicity and Response to Thiopurines in Patients With Inflammatory Bowel Disease

✍ Blaker, Paul A.; Fong, Steven C.; Walker, Jemma; Lewis, Cathryn; Corrigan, Adele 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 51 KB